Cargando…

Serum Galectin and Renal Dysfunction in ST-Segment Elevation Myocardial Infarction

This study aimed to evaluate the association between serum galectin levels and renal dysfunction in relation to in-hospital prognosis and unfavorable prognosis 1 year after ST-elevated myocardial infarction (STEMI). Patients were assigned to two groups according to the cystatin C-based estimate of G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karetnikova, Victoria, Osokina, Anastasia, Gruzdeva, Olga, Uchasova, Evgenya, Zykov, Michael, Kalaeva, Victoria, Kashtalap, Vasily, Shafranskaya, Kristina, Hryachkova, Oksana, Barbarash, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770136/ https://www.ncbi.nlm.nih.gov/pubmed/26980923 http://dx.doi.org/10.1155/2016/1549063

Ejemplares similares

Serum neutrophil gelatinase-associated lipocalin the estimation of hospital prognosis in patients with ST-elevated myocardial infarction
por: Karetnikova, Victoria, et al.
Publicado: (2017)

Glucose levels as a prognostic marker in patients with ST-segment elevation myocardial infarction: a case–control study
por: Karetnikova, Victoria, et al.
Publicado: (2016)

Serum neutrophil gelatinase-associated lipocalin has an advantage over serum cystatin C and glomerular filtration rate in prediction of adverse cardiovascular outcome in patients with ST-segment elevation myocardial infarction
por: Barbarash, Olga L., et al.
Publicado: (2017)

Serum and Echocardiographic Markers May Synergistically Predict Adverse Cardiac Remodeling after ST-Segment Elevation Myocardial Infarction in Patients with Preserved Ejection Fraction
por: Pecherina, Tamara, et al.
Publicado: (2020)

Prognostic Value of Soluble ST2 During Hospitalization for ST-Segment Elevation Myocardial Infarction
por: Barbarash, Olga, et al.
Publicado: (2016)

Association of inflammatory markers and poor outcome in diabetic patients presenting with ST segment elevation myocardial infarction
por: Belenkova, Yulia, et al.
Publicado: (2015)

Relationship between free fatty acids, insulin resistance markers, and oxidized lipoproteins in myocardial infarction and acute left ventricular failure
por: Gruzdeva, Olga, et al.
Publicado: (2013)

Biological markers and cardiac remodelling following the myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2019)

Early Effects of Treatment Low-Dose Atorvastatin on Markers of Insulin Resistance and Inflammation in Patients with Myocardial Infarction
por: Gruzdeva, Olga, et al.
Publicado: (2016)

Dose-dependent effects of atorvastatin on myocardial infarction
por: Barbarash, Olga, et al.
Publicado: (2015)

Biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control study
por: Barbarash, Olga, et al.
Publicado: (2017)

Impact of recipient-related factors on structural dysfunction of xenoaortic bioprosthetic heart valves
por: Barbarash, Olga, et al.
Publicado: (2015)

Increased Serum Parathyroid Hormone, Osteocalcin and Alkaline Phosphatase Are Associated with a Long-Term Adverse Cardiovascular Outcome after Coronary Artery Bypass Graft Surgery
por: Barbarash, Olga, et al.
Publicado: (2019)

Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2017)

Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2014)

The Prognostic Value of Peripheral Artery Diseases in Patients with ST-Segment Elevation Myocardial Infarction
por: Barbarash, Olga L., et al.
Publicado: (2013)

The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction
por: Barbarash, Olga, et al.
Publicado: (2016)

Relationship key factor of inflammation and the development of complications in the late period of myocardial infarction in patients with visceral obesity
por: Gruzdeva, Olga, et al.
Publicado: (2017)

Relationships between epicardial adipose tissue thickness and adipo-fibrokine indicator profiles post-myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2018)

Relationship between epicardial and perivascular fatty tissue and adipokine-cytokine level in coronary artery disease patients
por: Gruzdeva, Olga, et al.
Publicado: (2019)

Localization of fat depots and cardiovascular risk
por: Gruzdeva, Olga, et al.
Publicado: (2018)

Leptin resistance: underlying mechanisms and diagnosis
por: Gruzdeva, Olga, et al.
Publicado: (2019)

Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2013)

Lipid, adipokine and ghrelin levels in myocardial infarction patients with insulin resistance
por: Gruzdeva, Olga, et al.
Publicado: (2014)

Insulin resistance and inflammation markers in myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2013)

Prognostic potential of cardiac structural and functional parameters and N-terminal propeptide of type III procollagen in predicting cardiac fibrosis one year after myocardial infarction with preserved left ventricular ejection fraction
por: Osokina, Anastasia, et al.
Publicado: (2021)

Use of thrombin generation test for monitoring hemostasis in coronary bypass surgery
por: Gruzdeva, Olga, et al.
Publicado: (2017)

Adipocytes Directly Affect Coronary Artery Disease Pathogenesis via Induction of Adipokine and Cytokine Imbalances
por: Gruzdeva, Olga, et al.
Publicado: (2019)

Genetic forms and pathophysiology of essential arterial hypertension in minor indigenous peoples of Russia
por: Mulerova, Tatyana, et al.
Publicado: (2020)

Prosthetic heart valve selection in women of childbearing age with acquired heart disease: a case report
por: Barbarash, Leonid, et al.
Publicado: (2016)

Expression of Ceramide-Metabolizing Enzymes in the Heart Adipose Tissue of Cardiovascular Disease Patients
por: Gruzdeva, Olga, et al.
Publicado: (2023)

Trend of Galectin-3 Levels in Patients with Non-ST-Elevation and ST-Elevation Myocardial Infarction
por: Mitić, Branka, et al.
Publicado: (2022)

Effects of Physical Prehabilitation on the Dynamics of the Markers of Endothelial Function in Patients Undergoing Elective Coronary Bypass Surgery
por: Argunova, Yulia, et al.
Publicado: (2022)

Association of Galectin-3 and Soluble ST2, and Their Changes, with Echocardiographic Parameters and Development of Heart Failure after ST-Segment Elevation Myocardial Infarction
por: Tymińska, Agata, et al.
Publicado: (2019)

Expression of adipocytokines in heart fat depots depending on the degree of coronary artery atherosclerosis in patients with coronary artery disease
por: Gruzdeva, Olga V., et al.
Publicado: (2021)

Characteristics and mechanism of reciprocal ST-segment depression in acute ST segment elevation myocardial infarction: Reciprocal ST-segment depression and ST segment elevation myocardial infarction
por: Gao, Qijun, et al.
Publicado: (2022)

Screening for Glucose Metabolism Disorders, Assessment the Disse Insulin Resistance Index and Hospital Prognosis of Coronary Artery Bypass Surgery
por: Sumin, Alexey N., et al.
Publicado: (2021)

Circulating Cell and Plasma microRNA Profiles Differ between Non-ST-Segment and ST-Segment-Elevation Myocardial Infarction
por: Ward, Jeanine A, et al.
Publicado: (2013)

ST Segment Elevation with Normal Coronaries
por: Sethi, Pooja, et al.
Publicado: (2016)

False-positive ST-segment elevation
por: Tanabe, Junya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r6b17pkqntl8j21eiaq7nr8483